Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06061731Phase 1Completed
Phase 1, randomised trial (2 arms). Primary endpoint: Surface Electromyographic Eigenvalues (MAX and RMS) at 3 weeks. Started Jan 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06061731.